omniture
Harbour BioMed

Latest News

Harbour BioMed Announces Dosing of First Patients in Two Phase II Clinical Studies of Batoclimab (HBM9161) for the Treatment of Myasthenia Gravis and Immune Thrombocytopenia

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 30, 2020 /PRNewswire/ -- Harbo...

2020-09-30 21:50 3387

Harbour BioMed Announces Two China NMPA Clearances for Clinical Trials for Phase I & Combination Therapy of Next Generation Anti-CTLA-4 Antibody for Treatment of Solid Tumors

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 21, 2020 /PRNewswire/ -- Harbo...

2020-09-21 20:12 2083

Harbour BioMed and Hualan Genetic Announced Collaboration to Develop Multiple Innovative Antibody Programs

CAMBRIDGE, Mass., ROTTERDAM, Netherlands, SUZHOU,China and XINXIANG, China, Sept. 11, 2020 /PRNewsw...

2020-09-11 21:33 5654

Harbour BioMed Presented Its Newly Discovered Anti-Human CCR8 Novel Monoclonal Antibodies at the 16th PEGS Boston 2020

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI, Sept. 2, 2020 /PRNewswire/ -- Harbour Bi...

2020-09-02 11:40 1981

Harbour BioMed Will Present Its New Platform HBICE (Heavy chain only antibody (HCAb) Based Immune Cell Engager) at 16th PEGS Boston Summit

SHANGHAI, Aug. 31, 2020 /PRNewswire/ -- Harbour BioMed, a global, clinical-stage, innovative biopha...

2020-08-31 21:39 2519

Harbour BioMed Signs Strategic Collaboration Agreement with Vir Biotechnology to Develop Novel Therapies for Immuno-Oncology and Infectious Diseases

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Aug. 24, 2020 /PRNewswire/ -- Harbou...

2020-08-24 19:00 2184

Harbour BioMed Presented Its Newly Discovered BCMA x CD3 Bispecific Antibody at Cell Engager Summit 2020

CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SUZHOU, China, Aug. 21, 2020 /PRNewswire/ -- Harbour ...

2020-08-21 21:31 5458

Harbour BioMed Announces Strategic Partnership with Viva Biotech to Collaborate on Incubating Innovative Biotech Start-ups

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, SHANGHAI, China, July 31, 2020 /PRNewswire/...

2020-07-31 08:56 3378

Harbour BioMed Presented Pre-Clinical Data on A Fully Human Anti-CD73 Antibody at AACR Virtual Annual Meeting

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SHANGHAI, July 16, 2020 /PRNewswire/ -- Harbour Bi...

2020-07-16 18:00 2730

Harbour BioMed Appoints Dr. Jon Wigginton to its Scientific Advisory Board

CAMBRIDGE, Mass, ROTTERDAM, Netherlands...

2020-06-11 18:00 1497

Harbour BioMed Announces First Patient Dosing of Phase 1b/2a Study of Anti-FcRn Batoclimab for Treating Neuromyelitis Optica Spectrum Disorder

* First anti-FcRn PoC study for the treatment of NMOSD * Anti-FcRn antibody with potential to be...

2020-04-21 17:00 1513

Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. Announce Strategic Alliance to Discover, Develop and Commercialize Innovative Biologics

CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, May 6, 2019 /PRNewswire/ -- Harbour BioMed ...

2019-05-06 10:49 714